World's Best Scientists 2026 revealed!
Gordon Sussman

Gordon Sussman

Overview

Gordon Sussman is affiliated with the University of Toronto in Canada, where they have contributed extensively to medical research, particularly in the field of allergy and immunology. Their work spans various subfields including rheumatology, pathology and forensic medicine, genetics, immunology, and pharmacology.

Their research focuses on multiple key topics, including:

  • Urticaria and Related Conditions
  • Autoimmune Bullous Skin Diseases
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Drug-Induced Adverse Reactions
  • Dermatology and Skin Diseases
  • Mast cells and histamine
  • Chronic Lymphocytic Leukemia Research

Sussman has published an extensive collection of papers, with frequent venues being the Journal of Allergy and Clinical Immunology, Annals of Allergy Asthma & Immunology, The Journal of Allergy and Clinical Immunology In Practice, Revue française d'allergologie, and Allergy. Key papers in recent years include:

  • "The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria" (2021), published in Allergy
  • "Fenebrutinib in H1 antihistamine-refractory chronic spontaneous urticaria: a randomized phase 2 trial" (2021), published in Nature Medicine
  • "Autoimmune Diseases Are Linked to Type IIb Autoimmune Chronic Spontaneous Urticaria" (2021), published in Allergy Asthma and Immunology Research
  • "Efficacy and safety of garadacimab, a factor XIIa inhibitor for hereditary angioedema prevention (VANGUARD): a global, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial" (2023), published in The Lancet
  • "Cannabis-related allergies: An international overview and consensus recommendations" (2022), published in Allergy

In collaboration, Sussman frequently coauthors with researchers such as Marcus Maurer, Michihiro Hide, Ana M. Giménez-Arnau, Jonathan A. Bernstein, and Martin Metz. Their partnerships reflect multidisciplinary approaches in allergy research and clinical immunology.

Their publications demonstrate a consistent focus on clinical challenges related to allergies, autoimmune conditions, and drug reactions, contributing to evolving guidelines and therapeutic options.

Best Publications

  • The EAACI/GA 2 LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update

    T. Zuberbier;W. Aberer;R. Asero;C. Bindslev-Jensen

  • The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria.

    T Zuberbier;W Aberer;R Asero;A H Abdul Latiff

  • The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria.

    Torsten Zuberbier;Amir Hamzah Abdul Latiff;Mohamed Abuzakouk;Susan Aquilina

  • AR101 Oral Immunotherapy for Peanut Allergy

    Brian P Vickery;Andrea Vereda;Thomas B Casale

  • The burden of chronic spontaneous urticaria is substantial: Real-world evidence from ASSURE-CSU

    M. Maurer;M. Abuzakouk;F. Berard;W. Canonica

  • Latex allergy can induce clinical reactions to specific foods

    D. H. Beezhold;G. L. Sussman;G. M. Liss;G. M. Liss;Nan-Shan Chang

  • Latex allergy: epidemiological study of 1351 hospital workers.

    G M Liss;G L Sussman;K Deal;S Brown

  • Allergy to Latex Rubber

    Gordon L. Sussman;Donald H. Beezhold

  • The spectrum of IgE-mediated responses to latex.

    Gordon L. Sussman;Susan Tarlo;Jerry Dolovich

  • Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion among Children with Peanut Allergy: The PEPITES Randomized Clinical Trial

    David M. Fleischer;Matthew Greenhawt;Gordon Sussman;Philippe Bégin

  • Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor

    Hilary Longhurst;Marco Cicardi;Timothy Craig;Konrad Bork

  • Effect of Varying Doses of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Exposure Among Patients With Peanut Sensitivity: A Randomized Clinical Trial.

    Hugh A. Sampson;Hugh A. Sampson;Wayne G. Shreffler;William H. Yang;Gordon L. Sussman

  • Control of airborne latex by use of powder-free latex gloves

    Susan M. Tarlo;Gordon Sussman;Anne Contala;Mark C. Swanson

  • Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis.

    Alain Didier;Margitta Worm;Friedrich Horak;Gordon Sussman

  • Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST Study

    Nicole Schoepke;Riccardo Asero;André Ellrich;Marta Ferrer

  • Hypersensitivity to natural latex.

    D. Spaner;J. Dolovich;S. Tarlo;G. Sussman

  • Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial.

    Hendrik Nolte;David I. Bernstein;Harold S. Nelson;Jörg Kleine-Tebbe

  • Allergens and natural rubber proteins.

    Gordon L. Sussman;Donald H. Beezhold;Viswanath P. Kurup

  • Latex sensitization : Occupational versus general population prevalence rates

    Gary M. Liss;Gary M. Liss;Gordon L. Sussman

  • Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency ☆: A randomized double-blind trial

    Chaim M Roifman;Harry Schroeder;Melvin Berger;Ricardo Sorensen

Frequent Co-Authors

Donald H. Beezhold
Donald H. Beezhold National Institute for Occupational Safety and Health
Jacques Hébert
Jacques Hébert Université Laval
Marcus Maurer
Marcus Maurer Charité - University Medicine Berlin
Ana Giménez-Arnau
Ana Giménez-Arnau Autonomous University of Barcelona
Martin Metz
Martin Metz Charité - University Medicine Berlin
Michihiro Hide
Michihiro Hide Hiroshima University
Carsten Bindslev-Jensen
Carsten Bindslev-Jensen University of Southern Denmark
André C. Knulst
André C. Knulst Utrecht University
Torsten Zuberbier
Torsten Zuberbier Charité - University Medicine Berlin
Peter Schmid-Grendelmeier
Peter Schmid-Grendelmeier University of Zurich

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, pursuing related healthcare degrees can open doors to rewarding career paths. Many professionals transition into specialized nursing roles to complement their immunology knowledge. For example, exploring top psychiatric mental health nurse practitioner programs online offers valuable training with excellent clinical placement rates, which is crucial for hands-on experience.

Cost is often a decisive factor. Students looking for less expensive options while maintaining quality should consider the cheapest pmhnp programs. These affordable pathways can reduce the financial burden without compromising educational outcomes.

In terms of career advancement, understanding salary trends helps in making informed decisions. The highest paid dnp specialties provide insight into lucrative fields within healthcare, highlighting where your immunology expertise might be most valued.

For nurse practitioners seeking to expand their scope, programs like the fnp to acute care np bridge program offer a structured route to specialize in acute care settings. This transition can synergize well with a background in immunology, especially in managing complex patient cases.

Best Scientists Citing Gordon Sussman

Trending Scientists

Recently Published Articles